ProtoKinetix Inc. Outlines AAGP(TM) Values in CEO Interview

VANCOUVER, British Columbia--(BUSINESS WIRE)--ProtoKinetix (OTCBB: PKTX) (www.protokinetix.com), a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine, biotechnology and cosmetic industries today issued Question and Answer sessions with Ross L. Senior, CEO of ProtoKinetix regarding the effective uses of the AAGP™ molecule.

MORE ON THIS TOPIC